美因基因有限公司（股票代码：06667）于2026年3月3日公布2026年2月股份变动月报表。报告期内，公司法定股本总额保持在500,000,000股，面值均为每股USD 0.0001，总注册股本金额为USD 50,000，未发生任何变动。
\n\n根据公告披露，截至2026年2月28日，公司已发行股份维持在224,300,200股，未有任何购回、注销或库藏股行为，也无新增发行及其他股份变动。公司同时确认符合香港联交所对公众持股量的要求，没有违反任何适用的法规和上市规则。
\n\n公司确认在报告期内无期权及股权激励计划的变动，也无可换股票据或其他衍生工具之发行记录。公司声明所有相关交易均经董事会授权批准并遵守香港联交所《上市规则》及相关法律规定。本次月报由董事姜晶代表公司签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.